1. Home
  2. HAO vs GLUE Comparison

HAO vs GLUE Comparison

Compare HAO & GLUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HAO
  • GLUE
  • Stock Information
  • Founded
  • HAO 2018
  • GLUE 2019
  • Country
  • HAO China
  • GLUE United States
  • Employees
  • HAO N/A
  • GLUE N/A
  • Industry
  • HAO
  • GLUE Biotechnology: Pharmaceutical Preparations
  • Sector
  • HAO
  • GLUE Health Care
  • Exchange
  • HAO NYSE
  • GLUE Nasdaq
  • Market Cap
  • HAO 3.3M
  • GLUE 276.2M
  • IPO Year
  • HAO 2024
  • GLUE 2021
  • Fundamental
  • Price
  • HAO $1.41
  • GLUE $4.87
  • Analyst Decision
  • HAO
  • GLUE Buy
  • Analyst Count
  • HAO 0
  • GLUE 2
  • Target Price
  • HAO N/A
  • GLUE $13.50
  • AVG Volume (30 Days)
  • HAO 28.8K
  • GLUE 413.8K
  • Earning Date
  • HAO 07-11-2025
  • GLUE 08-07-2025
  • Dividend Yield
  • HAO N/A
  • GLUE N/A
  • EPS Growth
  • HAO N/A
  • GLUE N/A
  • EPS
  • HAO 0.19
  • GLUE 0.08
  • Revenue
  • HAO $48,970,924.00
  • GLUE $159,487,000.00
  • Revenue This Year
  • HAO N/A
  • GLUE $49.02
  • Revenue Next Year
  • HAO N/A
  • GLUE N/A
  • P/E Ratio
  • HAO $6.48
  • GLUE $62.33
  • Revenue Growth
  • HAO 15.04
  • GLUE 14889.38
  • 52 Week Low
  • HAO $0.84
  • GLUE $3.50
  • 52 Week High
  • HAO $173.25
  • GLUE $12.40
  • Technical
  • Relative Strength Index (RSI)
  • HAO 44.04
  • GLUE 57.86
  • Support Level
  • HAO $1.24
  • GLUE $4.42
  • Resistance Level
  • HAO $1.36
  • GLUE $4.85
  • Average True Range (ATR)
  • HAO 0.09
  • GLUE 0.27
  • MACD
  • HAO 0.00
  • GLUE -0.00
  • Stochastic Oscillator
  • HAO 48.12
  • GLUE 67.75

About HAO HAOXI HEALTH TECHNOLOGY LTD

Haoxi Health Technology Ltd is an online marketing solution provider in China, with an advertiser client base mainly in the healthcare industry. Haoxi has been rooted in the field of local online effect marketing for many years, serving customers in various industries at home and abroad, and its main business is the medical industry. It generates its revenue by providing one-stop online marketing solutions, in particular online short video marketing solutions, to advertisers through its media partners. The company provides customized marketing solutions by planning, producing, placing, and optimizing online ads, especially online short video ads, to help its advertisers acquire, convert, and retain ultimate consumers on various online media platforms.

About GLUE Monte Rosa Therapeutics Inc.

Monte Rosa Therapeutics Inc is a biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins. Utilizing the QuEEN platform, the company employ artificial intelligence and proprietary experimental tools to identify target proteins for degradation by MGDs. With a diverse library of over 50,000 MGD molecules, their product candidate, MRT-2359, targets the translation termination factor protein GSPT1 for potential use in MYC-driven tumors. The company's focus lies in advancing its pipeline of MGDs, aiming to provide novel therapeutic modalities for various diseases.

Share on Social Networks: